Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 08.04.2021.

Vaccination
Smallpox
Clinical trial
Lou Gehrig
Form 10-K
Antibody

Healthcare

@ldtimmerman shared
On Apr 7, 2021
Biogen has a predicament after denying a Compassionate Use request from an ALS patient. How it handles the situation could reverberate through the industry. By @danielmcintyre https://t.co/igo0c25Rwq
Open
Compassionate Use Policy Has Everything We Need…Except Policy and Compassion

Compassionate Use Policy Has Everything We Need…Except Policy and Compassion

Biogen is in a bind. The way it navigates a tricky compassionate use situation today could reverberate across the industry for years to come. Full disclosure before diving in — I used to ...

@BIODeutschland shared
On Apr 7, 2021
RT @Immutep: A great article on Immutep following Marc Voigt’s presentation at the Benzinga Biotech Small-Cap Conference. #immunotherapy #LAG3 https://t.co/90KvyGB235 via @Yahoo
Open
Biotech Immunotherapy Company Immutep Sets the Standard with its LAG-3 Research

Biotech Immunotherapy Company Immutep Sets the Standard with its LAG-3 Research

Immutep was one of the Benzinga Biotech Small Cap Conference held virtually on March 24 & 25, 2021. The information contained in this article in no way represents investment advice or ...

@Biotechnology shared
On Apr 7, 2021
Four Biopharma Companies Raise Big Bucks in Series B Financing Rounds https://t.co/lOy89RIdVE https://t.co/2WP5RxFGWj
Open
Four Biopharma Companies Raise Big Bucks in Series B Financing Rounds

Four Biopharma Companies Raise Big Bucks in Series B Financing Rounds

It takes money to develop new, innovative treatments and this morning, multiple companies have announced significant fundraises. A summary of each financing round is below.

@ldtimmerman shared
On Apr 6, 2021
John C. Martin of @GileadSciences was one of biotech's most successful leaders. He was essentially unknown to the public and not very well understood within his own industry. A former deputy, @cngarabedian, shed some light. https://t.co/ufJqYnQzN3
Open
The Glory of John Martin: an Understated Leader Who Built a Biotech Powerhouse

The Glory of John Martin: an Understated Leader Who Built a Biotech Powerhouse

John C. Martin was an unassuming man with an ordinary name. But his leadership qualities and accomplishments as a biopharma CEO were extraordinary. Martin, the CEO of Foster City, Calif. ...

@ldtimmerman shared
On Apr 7, 2021
RT @JunTangBiotech: “Biotech Investing Impact in Price-Controlled Future” with @cngarabedian, Peter Kolchinsky, @ldtimmerman, Stefan Prisacaru, @JebKeiper, and BioTech Clubhouse. Today, Apr 7 at 7:00 PM EDT on @joinclubhouse! https://t.co/xtVifEXDf7
Open
Biotech Investing Impact in Price-Controlled Future

Biotech Investing Impact in Price-Controlled Future

Wednesday, April 7 at 7:00pm EDT with Chris Garabedian, Peter Kolchinsky, Luke Timmerman, Stefan Prisacaru, Jeb Keiper. Can biotech startups attract investment in a price-controlled future? ...

@matthewherper shared
On Apr 4, 2021
$JNJ put in charge of Emergent plant. https://t.co/BIkA4DMTFd
Open
The Biden administration puts Johnson & Johnson in charge of a Baltimore plant that ruined millions of doses of its vaccine.

The Biden administration puts Johnson & Johnson in charge of a Baltimore plant that ruined millions of doses of its vaccine.

The Biden administration on Saturday put Johnson & Johnson in charge of a Baltimore contract plant that ruined 15 million doses of its Covid-19 vaccine, and moved to stop the …

@JNJInnovation shared
On Apr 2, 2021
RT @JNJNews: Johnson & Johnson announced it has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its investigational #COVID19 vaccine candidate. Read more: https://t.co/JEsRDMc5yf https://t.co/fBQvWwBvvd
Open
Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents

Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents

Expansion of ongoing trial to include adolescents 12-17 years of age reflects commitment to people of all ages affected by pandemic

@Prof_ChrisMason shared
On Apr 2, 2021
RT @OriBiotech: A new article from @medicine_maker explores the direct impact of BREXIT on Pharma and CGT. CEO Jason Foster shares his thoughts, discussing existing bottlenecks in the QA & QC process and why BREXIT will create an extra hurdle. Read the article: https://t.co/WHQlstr7iQ
Open
0321.pdf

0321.pdf

Feel free to contact any one of us: [email protected] Content Team Editor - Stephanie Sutton Charlotte Barker (Associate Content Director) James Strachan (Deputy …